RAP1GAP and head and neck carcinoma: Consistent with its ability to inactivate RAP1, RAP1GAP is a tumor suppressor in several human cancers, including endometrial (51), thyroid (52, 53), pancreas (54), colon (55), melanomas (56), prostate (57), and head and neck carcinomas (58).